These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37863401)

  • 1. TMT-based proteomics analysis identifies the interventional mechanisms of Qijia Rougan decoction in improving hepatic fibrosis.
    Chen X; Sun X; Ji S; Yu H; Wu P
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117334. PubMed ID: 37863401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis.
    Chen XF; Wang Y; Ji S; Sun X; Feng Q; Yu H; Liu C
    Front Pharmacol; 2022; 13():911250. PubMed ID: 35846987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl
    Li X; Xu X; Tao S; Su Y; Wen L; Wang D; Liu J; Feng Q
    Front Pharmacol; 2024; 15():1347120. PubMed ID: 38606180
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
    Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
    J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extract of Averrhoacarambola L. (Oxalidaceae) roots ameliorates carbon tetrachloride-induced hepatic fibrosis in rats.
    Huang X; Wang L; Meng M; Zhang S; Pham TTH; Jiang L; Chen L; Li Y; Zhou X; Qin L; Wu X; Zou C; Huang R
    Biomed Pharmacother; 2020 Jan; 121():109516. PubMed ID: 31704616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis.
    Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Su SB
    J Ethnopharmacol; 2021 Jan; 264():113021. PubMed ID: 32479885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jiawei Taohe Chengqi Decoction attenuates hepatic fibrosis by preventing activation of HSCs through regulating Src/ERK/Smad3 signal pathway.
    Huang Y; Wang ZL; He Y; Ye LM; Guo WQ; Zhang JJ
    J Ethnopharmacol; 2023 Apr; 305():116059. PubMed ID: 36549368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.
    Wang Y; Wang R; Wang Y; Peng R; Wu Y; Yuan Y
    Drug Des Devel Ther; 2015; 9():6303-17. PubMed ID: 26664050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-liver fibrosis effect of total flavonoids from Scabiosa comosa Fisch. ex Roem. et Schult. on liver fibrosis in rat models and its proteomics analysis.
    ; Yuan H; Zhao C; Bao X; Wang H; Liang J; Yan Y; Zhang C; Jin R; Ma L; Zhang J; Su X; Ma Y
    Ann Palliat Med; 2020 Mar; 9(2):272-285. PubMed ID: 32233617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
    Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
    J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway.
    Lan T; Chen B; Hu X; Cao J; Chen S; Ding X; Li S; Fu Y; Liu H; Luo D; Rong X; Guo J
    J Ethnopharmacol; 2024 Mar; 321():117516. PubMed ID: 38042390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tandem mass tag-based proteomics analysis reveals the multitarget mechanisms of
    Gong P; Yin K; Luo X; Gu J; Tan R; Wu Y; Li D
    Front Pharmacol; 2022; 13():989995. PubMed ID: 36313326
    [No Abstract]   [Full Text] [Related]  

  • 14. Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl
    Li HG; You PT; Xia Y; Cai Y; Tu YJ; Wang MH; Song WC; Quan TM; Ren HY; Liu YW; Dan HX; Xu SQ
    Curr Med Sci; 2020 Jun; 40(3):539-547. PubMed ID: 32681257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis.
    Jiang M; Huang C; Wu Q; Su Y; Wang X; Xuan Z; Wang Y; Xu F; Ge C
    J Ethnopharmacol; 2023 Mar; 303():115965. PubMed ID: 36460296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl
    Xiong Y; Hu J; Xuan C; Tian J; Tan K; Chen Z; Luo Y; Du X; Cheng J; Zhang L; Cao W
    Chin Med; 2021 Dec; 16(1):142. PubMed ID: 34952623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMT-based proteomics analysis reveals the protective effects of Xuefu Zhuyu decoction in a rat model of traumatic brain injury.
    Zhou D; Liu J; Hang Y; Li T; Li P; Guo S; Liu T; Xia Z; Wang Y
    J Ethnopharmacol; 2020 Aug; 258():112826. PubMed ID: 32298754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baihe Wuyao decoction ameliorates CCl
    Chen Y; Li R; Hu N; Yu C; Song H; Li Y; Dai Y; Guo Z; Li M; Zheng Y; Guo Z; Qi Y
    J Ethnopharmacol; 2020 Dec; 263():113227. PubMed ID: 32783983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvianolic acid A suppresses CCl
    Li S; Wang R; Song F; Chen P; Gu Y; Chen C; Yuan Y
    Drug Chem Toxicol; 2023 Mar; 46(2):304-313. PubMed ID: 35057680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis.
    Shi MJ; Yan XL; Dong BS; Yang WN; Su SB; Zhang H
    J Ethnopharmacol; 2020 May; 253():112689. PubMed ID: 32101775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.